CymaBay Therapeutics, Inc.
Total Trades
59
Buys
1
Sells
29
Largest Trade
N/A
Insiders
7
Institutional Funds
3
Inst. Value
$1M+
Activist Filings
17
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dorling Janet | Director | SELL | $100K–$500K | 6K | $31.97 | Feb 14, 2024 |
| Dorling Janet | Director | EXERCISE | $15K–$50K | 6K | $4.63 | Feb 14, 2024 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 18K | $7.09 | Jan 22, 2024 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 18K | $23.67 | Jan 22, 2024 |
| Menold Daniel | Vice President | SELL | $100K–$500K | 10K | $23.58 | Jan 17, 2024 |
| Menold Daniel | Vice President | EXERCISE | $15K–$50K | 10K | $4.05 | Jan 17, 2024 |
| Quinlan Paul T | General Counsel | SELL | $100K–$500K | 5K | $23.58 | Jan 17, 2024 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Jan 17, 2024 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 11K | $18.28 | Nov 17, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $50K–$100K | 11K | $5.00 | Nov 17, 2023 |
| Menold Daniel | Vice President | SELL | N/A | — | — | Nov 17, 2023 |
| Menold Daniel | Vice President | EXERCISE | $50K–$100K | 18K | $3.45 | Nov 17, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Nov 17, 2023 |
| Quinlan Paul T | General Counsel | SELL | $50K–$100K | 5K | $17.38 | Nov 17, 2023 |
| Shah Sujal | CEO | EXERCISE | $100K–$500K | 65K | $5.00 | Nov 14, 2023 |
| Shah Sujal | CEO | SELL | $1M+ | 65K | $15.89 | Nov 14, 2023 |
| Dorling Janet | Director | SELL | $100K–$500K | 7K | $15.24 | Nov 14, 2023 |
| Dorling Janet | Director | EXERCISE | $15K–$50K | 7K | $4.63 | Nov 14, 2023 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 22K | $14.07 | Oct 18, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 22K | $5.00 | Oct 18, 2023 |
| Menold Daniel | Vice President | EXERCISE | $50K–$100K | 18K | $3.45 | Oct 18, 2023 |
| Menold Daniel | Vice President | SELL | N/A | — | — | Oct 18, 2023 |
| Quinlan Paul T | General Counsel | SELL | $50K–$100K | 5K | $13.76 | Oct 18, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Oct 18, 2023 |
| Shah Sujal | CEO | EXERCISE | $100K–$500K | 65K | $5.00 | Oct 10, 2023 |
| Shah Sujal | CEO | SELL | $500K+ | 65K | $14.20 | Oct 10, 2023 |
| EMSTER KURT VON | Director | SELL | $100K–$500K | 16K | $15.68 | Sep 29, 2023 |
| EMSTER KURT VON | Director | EXERCISE | $50K–$100K | 16K | $5.00 | Sep 29, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 22K | $5.00 | Sep 19, 2023 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 22K | $16.22 | Sep 19, 2023 |
| Menold Daniel | Vice President | EXERCISE | $15K–$50K | 17K | $1.73 | Sep 19, 2023 |
| Menold Daniel | Vice President | SELL | N/A | — | — | Sep 19, 2023 |
| Quinlan Paul T | General Counsel | SELL | $500K+ | 53K | $16.87 | Sep 19, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $100K–$500K | 53K | $2.94 | Sep 19, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 22K | $5.00 | Aug 18, 2023 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 22K | $11.47 | Aug 18, 2023 |
| Menold Daniel | Vice President | SELL | N/A | — | — | Aug 16, 2023 |
| Menold Daniel | Vice President | EXERCISE | $50K–$100K | 16K | $5.10 | Aug 16, 2023 |
| Quinlan Paul T | General Counsel | SELL | $50K–$100K | 5K | $11.91 | Aug 16, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Aug 16, 2023 |
| Menold Daniel | Vice President | EXERCISE | $100K–$500K | 21K | $5.00 | Aug 11, 2023 |
| Menold Daniel | Vice President | SELL | $100K–$500K | 21K | $12.35 | Aug 11, 2023 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 22K | $11.43 | Jul 19, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 22K | $5.00 | Jul 19, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Jul 14, 2023 |
| Quinlan Paul T | General Counsel | SELL | $50K–$100K | 5K | $11.81 | Jul 14, 2023 |
| Quinlan Paul T | General Counsel | EXERCISE | $1K–$15K | 5K | $2.94 | Jun 30, 2023 |
| Quinlan Paul T | General Counsel | SELL | $50K–$100K | 5K | $10.05 | Jun 30, 2023 |
| McWherter Charles | President of R&D | SELL | $100K–$500K | 22K | $8.16 | Jun 21, 2023 |
| McWherter Charles | President of R&D | EXERCISE | $100K–$500K | 22K | $5.00 | Jun 21, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2023 · 3 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 95K | $1M+ | SH |
| Legal & General Group Plc | 12K | $100K–$500K | SH |
| Orion Porfolio Solutions, LLC | 12K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 14, 2024
3.5%
4.0M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Feb 14, 2024
5.4%
6.1M shares
SC 13G/A · Feb 14, 2024
10.0%
16.3M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.6%
6.3M shares
SC 13G/A · Feb 13, 2024
0.0%
0 shares
SC 13G · Jan 25, 2024
8.5%
9.6M shares
SC 13G · Sep 22, 2023
6.2%
6.9M shares
SC 13G · Sep 11, 2023
3.8%
3.7M shares
SC 13G · Mar 10, 2023
5.6%
5.3M shares
SC 13G/A · Feb 14, 2023
6.8%
5.7M shares
SC 13G/A · Feb 14, 2023
6.2%
5.9M shares
SC 13G · Jul 8, 2022
2.3%
1.9M shares
SC 13G/A · Feb 14, 2022
0 shares
SC 13G/A · Feb 14, 2022
7.8%
5.4M shares
SC 13G/A · Feb 11, 2022
14.7%
12.8M shares
SC 13G/A · Feb 1, 2022
6.3%
5.3M shares